Journal article
Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol
Abstract
BackgroundCentral nervous system tumors remain the leading cause of cancer-related mortality amongst children with solid tumors, with medulloblastoma (MB) representing the most common pediatric brain malignancy. Despite best current therapies, patients with recurrent MB experience have an alarmingly high mortality rate and often have limited therapeutic options beyond inadequate chemotherapy or experimental clinical trials. Therefore, a …
Authors
Adile AA; Kameda-Smith MM; Bakhshinyan D; Banfield L; Salim SK; Farrokhyar F; Fleming AJ
Journal
Systematic Reviews, Vol. 9, No. 1,
Publisher
Springer Nature
Publication Date
December 2020
DOI
10.1186/s13643-020-01307-8
ISSN
2046-4053